Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

16.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.6K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

1.0K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

13.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

659
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
659
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

559
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
559

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort Study.

Mediterranean journal of rheumatology·2026
Same author

Healthcare providers' awareness and knowledge of recommendations on cardiovascular risk management in people with rheumatic and musculoskeletal diseases: a survey study.

EULAR rheumatology open·2026
Same author

Pathogenetic and clinical aspects of fibromyalgia: one year in review 2026.

Clinical and experimental rheumatology·2026
Same author

Long-term outcomes and prognosis of mixed cryoglobulinaemia: a European multicentre study of 1294 patients.

Rheumatology (Oxford, England)·2026
Same author

Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration.

The Journal of rheumatology·2026
Same author

Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al.

Journal of psoriasis and psoriatic arthritis·2026
Same journal

GRAPPA 2019 Research Recipient Awards Report.

The Journal of rheumatology. Supplement·2021
Same journal

GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting.

The Journal of rheumatology. Supplement·2021
Same journal

GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting.

The Journal of rheumatology. Supplement·2021
Same journal

Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.

The Journal of rheumatology. Supplement·2021
Same journal

GRAPPA 2020 Update From the Education Committee.

The Journal of rheumatology. Supplement·2021
Same journal

The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop.

The Journal of rheumatology. Supplement·2021
See all related articles

Related Experiment Video

Updated: Mar 30, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.0K

Psoriatic Arthritis Registries.

Piercarlo Sarzi-Puttini1, Valentina Varisco1, Maria Chiara Ditto1

  • 1From the Rheumatology Unit, L. Sacco University Hospital, and the Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Galeazzi Orthopedic Institute, Milan; and the Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.P. Sarzi-Puttini, MD, PhD, Consultant Rheumatologist and Head of Rheumatology Unit; V. Varisco, MD, Resident in Rheumatology; M.C. Ditto, MD, Specialist Rheumatologist, Rheumatology Unit, L. Sacco University Hospital; M. Benucci, MD, Consultant Rheumatologist, Rheumatology Unit, San Giovanni di Dio Hospital; F. Atzeni, MD, PhD, Clinical Research in Rheumatology, IRCCS Galeazzi Orthopedic Institute.

The Journal of Rheumatology. Supplement
|November 3, 2015
PubMed
Summary
This summary is machine-generated.

Registries for rheumatoid arthritis and spondyloarthritis provide valuable data on biological drugs. More registries are needed for psoriatic arthritis to gather reliable patient data.

Keywords:
ADVERSE EVENTSBIOLOGICAL DRUGSPSORIATIC ARTHRITISREGISTRIES

More Related Videos

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

3.5K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

7.1K

Related Experiment Videos

Last Updated: Mar 30, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.0K
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

3.5K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

7.1K

Area of Science:

  • Rheumatology
  • Clinical Pharmacology
  • Health Services Research

Background:

  • Numerous registries exist in Europe and the US for rheumatoid arthritis and spondyloarthritis treatments.
  • These registries, often society-sponsored, collect data on biological drug characteristics, efficacy, and safety.
  • Existing data aids clinical practice, patient quality of life assessment, and resource allocation.

Purpose of the Study:

  • To highlight the utility of existing biological drug registries.
  • To emphasize the need for increased psoriatic arthritis registries.
  • To advocate for enhanced data collection in psoriatic arthritis.

Main Methods:

  • Analysis of existing biological drug registry data in rheumatology.
  • Review of registry sponsorship and data scope.
  • Identification of data gaps, particularly for psoriatic arthritis.

Main Results:

  • Registries for rheumatoid arthritis and spondyloarthritis yield clinically relevant information.
  • Data covers drug characteristics, patient-reported outcomes, and safety profiles.
  • A significant deficit in psoriatic arthritis registries was identified.

Conclusions:

  • Existing registries are crucial for understanding biological therapies in rheumatology.
  • Expanding psoriatic arthritis registries is essential for robust data collection.
  • Increased registry efforts will improve psoriatic arthritis patient care and research.